Kromek Group PLC (LON:KMK) CEO Arnab Basu talks to Proactive London's Katie Pilbeam about the plans for their £13mln raise through a firm placing, directors' subscription and open offer at 15p per share.
He explains how the money will be spent to increase the rate of commercialisation, sales and marketing of its nuclear detection and medical imaging ranges. As well as their range of bio-security/pathogen detectors.